| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expenses) | -308,801 | -16,263 | 45,093 | 129 |
| Net loss | -5,409,791 | -6,314,070 | -5,476,627 | -5,868,578 |
| Net loss attributable to non-controlling interest | - | 29,992 | -52,868 | -47,049 |
| Net income (loss) available to common stockholders, basic | - | - | - | -5,821,529 |
| Net loss attributable to volitionrx limited stockholders | - | -6,284,078 | -5,423,759 | - |
| Foreign currency translation adjustments | - | - | - | -141,980 |
| Foreign currency translation adjustments | 22,348 | -575,996 | - | - |
| Net comprehensive loss | -5,387,443 | -6,890,066 | - | -6,010,558 |
| Basic & diluted eps | - | - | - | -0.07 |
| - basic and diluted | 108,213,068 | 102,654,095 | 96,536,052 | - |
| Net loss per share - basic and diluted attributable to volitionrx limited stockholders | -0.05 | -0.06 | -0.06 | - |
VOLITIONRX LTD (VNRX)
VOLITIONRX LTD (VNRX)